focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,982.00
Bid: 1,978.00
Ask: 1,980.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.101%)
Open: 1,983.00
High: 1,991.00
Low: 1,971.00
Prev. Close: 1,983.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Strong start to final quarter

Fri, 01st Oct 2010 16:41

The last quarter of 2010 started well for London's leading share index, with buoyancy in the oil sector helping to offset continuing economic worries at home and abroad.Manufacturing data was subdued. Footsie gave up some of its early gains after figures from the US showed Manufacturing grew at the slowest pace in 12 months in September, with the Institute for Supply Management's factory index falling to 54.4 from 56.3. The US figures are still ahead of our manufacturing PMI index, which fell to 53.4 in September from 53.7, but the read was lower than expected. More worrying was Ireland, where the purchasing managers' index falling to 48.4 from 51.1 in August. For all these figures, a reading above 50 indicates expansion.Oil companies attracted buying interest. BP climbed amid speculation that dividends will soon be resumed. Bob Dudley, who becomes chief executive of the oil company today, said that the board would meet soon to discuss restoring payouts next year, according to newspaper reports. BP's rival BG did better still. BG's Spanish peer Repsol has announced a deal with the Chinese refiner Sinopec, which will result in Sinopec holding a 40% stake in Repsol's Brazilian unit. BG Group and Repsol have been exploring for oil in waters of Brazil in partnership and the deal is also seen as supportive to BG.Mexican miner Fresnillo got a boost from JPMorgan Cazenove, which has lifted its price target for the stock from 990p to 1400p, but fellow gold and silver miner Hochschild slipped back after Cazenove switched its rating from "overweight" to "neutral".In the FTSE 250, drugs group Hikma Pharmaceuticals moved to calm fears about the impact of a plan by US regulators to ban unapproved oral colchicine products to treat gout. The company said it will comply with any FDA regulatory requirements related to the sale of colchicine "if such a notice is served", but still predicts 20% revenue growth for its US generics business for the full year 2010 "irrespective of the timing of such notification".Having thought about it all week Cooper Controls has launched a rival bid for Mount Engineering at 82p a share, topping Redhall's 70p a share offer. Spectris, the mid-cap instrumentation and controls company, has bought American maker of rugged industrial networking components N-TRON for $51m (£32m).Shares in Iomart, a provider of data management, email and IT security services, rose sharply after it said interim results should beat expectations as clients seek to embrace new IT solutions.Leni Gas & Oil has entered into heads of agreement for a nitrogen enhanced oil recovery pilot project in Spain, which could increase recoverable reserves by one-third.Oil explorer Bowleven has agreed a revised option agreement with Vitol E&P Limited (Vitol) in respect of the Etinde Permit, offshore Cameroon.Hardide, the surface engineering technology provider, expects revenue for the year ended 30 September to exceed management budget. Other financial indicators are also expected to be better than internal forecasts, especially cash reserves, which at present are ahead of budget.FTSE 100 - RisersBG Group (BG.) 1,168.50p +4.47%BP (BP.) 440.50p +2.97%ARM Holdings (ARM) 403.80p +2.96%Lonmin (LMI) 1,712.00p +2.58%Capital Shopping Centres Group (CSCG) 376.90p +2.50%Amec (AMEC) 1,010.00p +2.43%Fresnillo (FRES) 1,270.00p +2.25%Randgold Resources (RRS) 6,510.00p +2.20%Tullow Oil (TLW) 1,302.00p +2.20%Vedanta Resources (VED) 2,209.00p +2.03%FTSE 100 - FallersExperian Group (EXPN) 673.00p -2.89%Aggreko (AGK) 1,534.00p -2.29%Man Group (EMG) 214.70p -2.01%Compass Group (CPG) 521.00p -1.79%Associated British Foods (ABF) 1,031.00p -1.72%Cobham (COB) 227.20p -1.65%SABMiller (SAB) 2,006.50p -1.42%Aviva (AV.) 393.50p -1.35%Rolls-Royce Group (RR.) 595.50p -1.33%Serco Group (SRP) 607.50p -1.22%FTSE 250 - RisersVictrex (VCT) 1,338.00p +4.86%Helical Bar (HLCL) 312.00p +4.84%Pace (PIC) 182.00p +4.60%Afren (AFR) 115.30p +4.25%Enterprise Inns (ETI) 111.40p +3.92%Kenmare Resources (KMR) 20.90p +3.83%DS Smith (SMDS) 154.80p +3.61%Derwent London (DLN) 1,557.00p +3.52%Hargreaves Lansdown (HL.) 453.90p +3.16%Hunting (HTG) 640.50p +3.06%FTSE 250 - FallersCSR (CSR) 344.30p -4.09%Jardine Lloyd Thompson Group (JLT) 562.00p -2.68%Centamin Egypt (CEY) 173.10p -2.20%Homeserve (HSV) 430.00p -2.16%Yell Group (YELL) 14.47p -2.03%ITE Group (ITE) 175.00p -1.91%Phoenix Group Holdings (PHNX) 672.00p -1.90%United Business Media (UBM) 618.50p -1.75%Moneysupermarket.com (MONY) 80.55p -1.71%National Express Group (NEX) 238.40p -1.61%
More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.